RNA Leaders Podcast Series
WITH
Michelle Werner, CEO,  Alltrna

Join RNA Leaders's Kaitlin Dailey kicking off the RNA Leaders podcast series as she welcomes Michelle Werner, CEO of Alltrna.  Michelle shares her extensive experience in the pharmaceutical industry, highlighting her transition from oncology to biotech, focusing on rare genetic diseases.

In this insightful conversation, Michelle discusses Alltrna's groundbreaking work with engineered transfer RNA (tRNA) technology, designed to tackle a wide range of genetic disorders. Learn about the company's recent progress, including the successful Series B funding round and the exciting advancements in their tRNA platform.

Tune in to discover the future of RNA therapeutics and get a sneak peek into what Alltrna will be presenting at the RNA Leaders USA conference this September.